These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35691247)

  • 1. The role of A-kinase interacting protein 1 in regulating progression and stemness as well as indicating the prognosis in glioblastoma.
    Tang J; Peng S; Yan H; Ni M; Hou X; Ma P; Li Y
    Transl Oncol; 2022 Aug; 22():101463. PubMed ID: 35691247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKIP1 promotes glioblastoma viability, mobility and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-κB and AKT pathways.
    Han D; Zhang N; Zhao S; Liu H; Wang X; Yang M; Wang S; Li Y; Liu Z; Teng L
    Am J Cancer Res; 2021; 11(4):1185-1205. PubMed ID: 33948353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A-Kinase Interacting Protein 1 Promotes Cell Invasion and Stemness
    Luo Z; Luo Y; Xiao K
    Front Oncol; 2021; 11():798557. PubMed ID: 35355804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression.
    Wan S; Liu C; Li C; Wang Z; Zhao G; Li J; Ran W; Zhong X; Li Y; Zhang L; Cui H
    Oncogene; 2023 Sep; 42(39):2905-2918. PubMed ID: 37596322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-Kinase Interacting Protein 1 Knockdown Restores Chemosensitivity
    Zheng H; Lin Q; Rao Y
    Front Oncol; 2022; 12():854702. PubMed ID: 35965570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
    Zhang X; Liu S; Zhu Y
    Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
    Chen H; Yan S; Dong L; Li X
    J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A-kinase interacting protein 1 regulates the cell proliferation, invasion, migration and angiogenesis of clear cell renal cell carcinoma cells and affects the ERK/c-Myc signaling pathway by binding to Rac1.
    Zhang Y; Zhang H; Han Z; Wang X; Li X; Yuan P; Ji S; Liu Q
    Exp Ther Med; 2022 Sep; 24(3):558. PubMed ID: 35978938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKIP1 promotes tumor progression by cancer-related pathways and predicts prognosis in tongue squamous cell carcinoma.
    Wang N; Bai D; Kristiansen E; Deng R; Zhang S
    Am J Transl Res; 2021; 13(11):12338-12351. PubMed ID: 34956456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Liu Q
    J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
    Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
    Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
    Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
    Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPM7 Induces Tumorigenesis and Stemness Through Notch Activation in Glioma.
    Wan J; Guo AA; King P; Guo S; Saafir T; Jiang Y; Liu M
    Front Pharmacol; 2020; 11():590723. PubMed ID: 33381038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β-catenin.
    Wang K; Park JO; Zhang M
    J Gene Med; 2013 Jan; 15(1):42-50. PubMed ID: 23319157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of AKIP1 predicts poor prognosis of patients with breast carcinoma and promotes cancer metastasis through Akt/GSK-3β/Snail pathway.
    Mo D; Li X; Li C; Liang J; Zeng T; Su N; Jiang Q; Huang J
    Am J Transl Res; 2016; 8(11):4951-4959. PubMed ID: 27904695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3BDO inhibits the proliferation, epithelial-mesenchymal transition (EMT), and stemness via suppressing survivin in human glioblastoma cells.
    Wang Z; Li Y; Liu M; Chen D; Lu J; Ji Y; Xing Z; Wang Y
    J Cancer; 2022; 13(4):1203-1213. PubMed ID: 35281871
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384.
    Zhu Y; Shah K
    Cancer Biol Ther; 2014 Jun; 15(6):815-22. PubMed ID: 24658109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia.
    Wang P; Zhao L; Gong S; Xiong S; Wang J; Zou D; Pan J; Deng Y; Yan Q; Wu N; Liao B
    Cell Death Dis; 2021 Mar; 12(4):312. PubMed ID: 33762574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.